Ding Chuan Tang, a Chinese herb decoction, could improve airway hyper‐responsiveness in stabilized asthmatic children: a randomized, double‐blind clinical trial*
- 4 July 2006
- journal article
- research article
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 17 (5) , 316-322
Abstract
Traditional Chinese medicine has a long history of application in the treatment of bronchial asthma. Solid scientific evidence, however, is not available despite its widespread use among patients worldwide and in Taiwan. To assess the effect of Ding Chuan Tang (DCT) in airway hyper‐responsiveness (AHR) on asthmatic children via randomized, double blind, placebo‐controlled clinical trial. This study enrolled children who were aged 8–15 and diagnosed as mild to moderate persistent asthma patients. They were randomly allocated to receive 6.0 g DCT or placebo daily for 12 wk. Self‐recorded daily symptom scores, medication scores, and morning and evening peak expiratory flow rates were returned at the monthly clinic. Pulmonary function test, methacholine challenge test, and serum inflammatory mediators were measured before and at the end of the trial. Fifty‐two asthmatic children completed the clinical study. Twenty‐eight patients were assigned to the treatment group and 24 to the placebo group. At the end of the treatment period, AHR determined by log PC20 was significantly improved in the DCT group (0.51 ± 1.05 mg/ml vs. 0.26 ± 0.84 mg/ml, p = 0.034). The total clinical and medication reduced parameters showed improvement in the DCT group (p = 0.004). The AHR, symptom and medication scores in children with persistent asthma were significantly improved with DCT treat for 12 wk. The results suggested more stable airways achieved with such an add‐on complementary therapy.Keywords
This publication has 28 references indexed in Scilit:
- Prevalence and severity of symptoms of asthma, rhinitis, and eczema in 13- to 14-year-old children in Taipei, TaiwanAnnals of Allergy, Asthma & Immunology, 2005
- The prevalence, severity and seasonal variations of asthma, rhinitis and eczema in Taiwanese schoolchildrenPediatric Allergy and Immunology, 2005
- Immunomodulatory effect of the antiasthma Chinese herbal formula MSSM-002 on TH2 cellsJournal of Allergy and Clinical Immunology, 2004
- Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroidsAnnals of Allergy, Asthma & Immunology, 2003
- The Chinese herbal formulation Biminne in management of perennial allergic rhinitis: a randomized, double-blind, placebo-controlled, 12-week clinical trialAnnals of Allergy, Asthma & Immunology, 2002
- Airway remodelling in the pathogenesis of asthmaCurrent Opinion in Allergy and Clinical Immunology, 2001
- Herbal medicines for asthma: a systematic reviewThorax, 2000
- The Chinese herbal medicine formula MSSM-002 suppresses allergic airway hyperreactivity and modulates TH1/TH2 responses in a murine model of allergic asthmaJournal of Allergy and Clinical Immunology, 2000
- Alternative medicine for allergy and asthmaJournal of Allergy and Clinical Immunology, 2000
- Evaluation of efficacy of traditional Chinese medicines in the treatment of childhood bronchial asthma: clinical trial, immunological tests and animal studyPediatric Allergy and Immunology, 1996